Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients.
BMJ Open
; 12(4): e061864, 2022 04 15.
Article
in En
| MEDLINE
| ID: mdl-35428650
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Kidney Transplantation
/
T-Lymphocytes, Regulatory
Type of study:
Clinical_trials
/
Guideline
Aspects:
Ethics
Limits:
Humans
Language:
En
Journal:
BMJ Open
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: